Published in Blood Weekly, November 29th, 2001
The study utilizes a new instrument that permits, for the first time, precise measurement of blood viscosity by eliminating the need for anticoagulants in viscosity testing. Visco Technologies, Inc., of Pennsylvania, which developed the instrument, is sponsoring the study.
"This is the first randomized placebo-controlled trial to examine the effects of different doses of aspirin on viscosity in unadulterated blood," said Robert S. Rosenson, MD, director of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.